The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Sent a similar message last Friday but more to the point, got what seems like a automated reply blaming someone else
Sent this to HL earlier today.
Good afternoon,
I wish to now raise a complaint formally with you regarding the with holding of my MDAI shares.
You have had more than enough time to provide me my shares, and this feels like fraudulent activity to me.
I will now contact the financial ombudsman service and forward my complaint to them for investigation.
Hi - I have my shares issued by Halifax and they are tradable (not that I'm going to!!). I contacted them a number of times and asked how I escalate my dissatisfaction at the lack of information and time that it was taking: their response was that they could not put a timescale on it, but the shares magically appeared within 48 hours.
I would advise persistence and enquiring how to escalate.
I have just spoken to ii who stated that they have no idea when the new shares will be placed to my account as there is no fixed time scale.
Well this is the reply today from ii:
Thank you for your secure message.
We are waiting to receive the new US listed shares, we have chased the international custodian on this matter. However, we have not yet received the new shares.
Not at all impressed.
Yes, I had heard nothing from them. Then in my message yesterday I mentioned that it is widely suspected that naked short trading is going on, then suddenly I get a message this morning telling me that my shares are now deposited and available at market open.
Our brokers are " Borrowing" our shares. Keeping liquidity low.
AJ Bell have informed me this morning that my shares have been deposited in my account and should be available to trade at market open (although I'm obviously not going to sell). I did put some pressure on them last night, so don't know if that is just a coincidence. Hopefully some of the other brokerages will also be delivering the shares. Saw pre-market up 24% there, so hopefully a good sign.
Https://twitter.com/CenterPointSec/status/1716892314793017782
In this post it claims that MDAI has one of the highest borrow rates. So it seems the shorters, naked or otherwise, are sill camping out in out stock.
Had a wee top up today. Will give HL another week before escalating it. I’ve had communications with their customer relations before. Is it correct that Halifax have issued shares and that they are tradable.
Strange how the brokers and the company have no desire to elaborate on what "complicated" means. Almost as if they have no justification for any of this without incriminating themselves.
I hope they sort it out soon and release the shares.
What they are doing to the SP now is sickening!
I sent them a message saying what Vincent Capone said. I just got back the same answer before. It was complicated and no time frame
Still waiting on those HL w-anchors.
The good news keeps flowing, but the share price continues to drop. The ambition here is big and given the appointment and his worldwide knowledge you have to believe this is going to grow rapidly at some point.
DALLAS, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI)
(“Spectral AI” or the “Company”), an artificial intelligence (AI)
company focused on medical diagnostics for faster and more accurate treatment
decisions in wound care, today announced the appointment of Prof. Paul
Chadwick as Executive Vice President of the Company’s United Kingdom
subsidiary. Prof. Chadwick is an experienced clinical scientist and wound care
key opinion leader (KOL) with an impressive body of work including a
substantial and impactful publication record, particularly in the domain of
diabetic wound management. He will be responsible for the international market
expansion of the Company’s DeepView(®) wound imaging technology in the
United Kingdom, Europe, Middle East and Africa (EMEA), all of which are
geographic areas where Prof. Chadwick has extensive clinical networks,
significant experience and has enjoyed previous successes.
“Paul brings over fifteen years of invaluable expertise in the medical
devices and technology sectors to our team. The Royal College of Podiatry is
an extremely prestigious and important organization where Paul most recently
served for over six years in senior executive capacities, including CEO. We
are highly confident that his addition will significantly enhance our efforts
in advancing the widespread adoption of the DeepView(®) System,” said Niko
Pagoulatos, the Company’s COO. “Spectral AI continues to strengthen its
leadership team and Paul’s experience in diabetic foot ulcers and clinical
wound management will contribute to our growth and enhance our capacity to
innovate.”
Prof. Chadwick’s impressive journey stretches across clinical, academic and
business disciplines. In his previous roles at the Royal College of Podiatry,
Prof. Chadwick led all the clinical, educational and financial aspects of the
organization. In addition, he has held multiple leadership positions such as
consultant podiatrist at The National Health Service (NHS), and Managing
Director at Curativo Wound Care Consultancy, where he has served companies
such as 3M, Molnlycke Health Care, Smith & Nephew, Advancis, Thornton & Ross,
Essity and many others. In his capacity as a prominent authority in wound
care, Prof. Chadwick fulfills critical roles on advisory boards and
exemplifies best practices in the field. Furthermore, he generously imparts
his knowledge as an adjunct professor at Birmingham City University, where he
teaches in the Health and Life Sciences Department.
I've had mine (through Halifax Share Dealing) for a couple of weeks now - it's quite unbelievable in these modern times that people are waiting on paper transactions for what could be significant financial issues, and all we have been able to do is stare forlornly at a screen which is literally dissolving our investment. I long for a day when the Shorters (naked or otherwise) move on and leave us to see what this can actually do.
No. Rang up ii last week and they said there had been a problem at their end but this had now been resolved and the shares should be with me early this week, but still nothing.
Has everyone got their shares?
Looks like they are still naked shorting it. Unbelievable!
As expected encouraging Financial Guidence as I anticipate the Company going from strength to strength over the coming weeks, months and years with the brilliant devices that they have now and for which there will be demand globally, I am sure, in the fullness of time. However, I do wonder if a mistake was made by leaving AIM but time will tell though I know that I shall never go near Nasdaq again. I was pleased to see that shareholders were mentioned in the report. I am still awaiting MDAI shares after 6 weeks!
MDAI have just delivered the following guidance
Financial Guidance
* Research & Development Revenue (“Revenue”) for FY2023 is expected to
approximate $17.4 million
* Revenue for FY2024 is expected to approximate $28.0 million
“We are on the cusp of delivering a distinct, cutting-edge AI-driven wound
healing assessment platform with the potential to significantly improve the
current standard of care across multiple indications,” said Wensheng Fan,
CEO of Spectral AI. “As we continue to advance our burn indication, we are
as excited about the prospects for the use of DeepView(®) for DFU, an
estimated $11.0 billion market that we believe is in dire need of a solution
that provides clinicians with an immediate healing assessment for more
accurate and timely diagnosis and therapeutic intervention. We intend to
submit applications for FDA, UKCA, and CE mark approval for the DeepView(®)
DFU indication, as well as for 3D wound measurement capabilities, in FY2024
subject to the completion of ongoing studies.”
The Company noted that the financial guidance for FY2024 does not reflect the
material financial contributions it expects would result from the
commercialization of DeepView(®) for DFU and 3D wound measurement following
the receipt of necessary regulatory clearances. As previously disclosed, the
Company has received regulatory approval for the DeepView SnapShot(®) device
and the Company will now seek the approval of its integrated AI application to
obtain both UKCA and FDA approval for the commercialization of the complete
DeepView SnapShot(®) System in the United States and across the globe.
“We believe we are in the best position in our history to deliver
significant value for patients dealing with acute and chronic wound
conditions, physicians and health systems that are challenged with effectively
and cost-efficiently managing these conditions, and, of course, our
shareholders,” Mr. Fan concluded.
The article on Naked Short Trading I found extremely interesting, thank you, Medjed. Let us hope that the activity of the Naked Short Traders is now reduced drastically and all the UK shareholders will have received their MDAI shares very shortly.
I agree with Oliiemarples that there will be lots of positive news to come, I believe, over many years and not only from hospitals but maybe also from military worldwide. My confidence and I feel that of many UK shareholders is at a low ebb regarding the Nasdaq dealings recently but with the share price being so depressed perhaps many will be holding on to their shares for the time being and as mentioned previously some real investment could well see an increase in share value over the next few months.
Watty,
Honestly, I have no idea how this is going to pay out. Hopefully someone more knowledgeable will give their opinion, I am curious too.
I too was not expecting the massive naked short attack on MDAI when it launched on NASDAQ.
I am hoping that at least when all the SMD share holders receive their MDAI shares thing will be better. And am hoping the true value of the company has to be reflected in the MCAP and SP eventually.
The thing that worries me the most is the naked shorting. If they have left and its only 'ordinary' shorters left, I hope things are more hopeful.
Have a read of this article which lays out how naked shorting works in reality, and how it is supported by the SEC.
https://prospect.org/power/gamestop-mess-exposes-the-naked-short-selling-scam/
If we keep getting positive news over the next 6-12 months which I do expect, the market can't keep down the share price it's impossible. There will simply be a huge gap up or gradual rise to its true market value. So sit and hold tight and we will all see the fruits sooner or later I'm sure.
Thank you, Medjed.
I had expected to see the share price much higher now than what it is for the reasons you have mentioned regarding the Grant and Certifications. However, whilst we were warned that there would be volatility in the share price to begin with I had not expected such a long delay in the UK shareholders receiving their new shares which, I believe, has been one reason, for so much activity in the market linked to "shorters, options, gamblers and day traders".
I continue to have great faith in Spectral and its products but I am wondering now how the share price is going to react over the next few weeks and months and if the shorters, hedgefunds and others will keep the price depressed. Any comments will be appreciated because I am not knowledgeable on their workings.
Zak said (I’m paraphrasing)
We want to see a end of day close above $4.4 to give us a chance of $10 but its early days.
He only does charting so none of the fundamentals are considered in his analysis.
Personally I am surprised its not above $10 already with the Barda contract win and the FDA and UKCA certification.
I bet if it was on AIM / FTSE it would have multi bagged already.
Nasdaq seems to be full of shorters, options gamblers and day traders.